MHRA Drug Safety Update January 2021
- Antiepileptic drugs in pregnancy: updated advice following comprehensive safety review
- COVID-19 vaccines (Pfizer/BioNTech and COVID-19 Vaccine AstraZeneca): current advice
- Dimethyl fumarate (Tecfidera): updated advice on the risk of progressive multifocal leukoencephalopathy (PML) associated with mild lymphopenia
- Fingolimod (Gilenya▼): updated advice about the risks of serious liver injury and herpes meningoencephalitis
- SSRI/SNRI antidepressant medicines: small increased risk of postpartum haemorrhage when used in the month before delivery
- Aminoglycosides (gentamicin, amikacin, tobramycin, and neomycin): increased risk of deafness in patients with mitochondrial mutations
You can sign up to receive these alerts directly from the MHRA at: MHRA email alerts
Published: 29/01/2021. Medicines Update blogs are correct at the time of publication.